SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) informs about updation on sales order received

21 Aug 2023 Evaluate
Pursuant to Regulation 30 (4) read with guidelines of materiality in accordance with the SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023, Syschem (India) has submitted that the company has received sales order of an amount of Rs 83,23,.425 only from its Customers towards Supply of Products manufactured by the Company. It has also enclosed details as required to be disclosed in terms of SEBI Circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015 and enclosed as Annexure.

The above information is a part of company’s filings submitted to BSE.

Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×